Heart Failure with Preserved Ejection Fraction in Children

被引:0
|
作者
Bibhuti Das
Shriprasad Deshpande
Jyothsna Akam-Venkata
Divya Shakti
William Moskowitz
Steven E. Lipshultz
机构
[1] University of Mississippi Medical Center,Department of Pediatrics, Division of Cardiology
[2] Children’s National Hospital,Department of Pediatrics
[3] The George Washington University,Department of Pediatrics, Jacobs School of Medicine and Biomedical Sciences
[4] University at Buffalo,undefined
[5] Oishei Children’s Hospital,undefined
来源
Pediatric Cardiology | 2023年 / 44卷
关键词
HFpEF: Heart failure with preserved ejection fraction; Pediatric; Child; Adolescents; Diastolic heart failure;
D O I
暂无
中图分类号
学科分类号
摘要
Diastolic dysfunction (DD) refers to abnormalities in the mechanical function of the left ventricle (LV) during diastole. Severe LVDD can cause symptoms and the signs of heart failure (HF) in the setting of normal or near normal LV systolic function and is referred to as diastolic HF or HF with preserved ejection fraction (HFpEF). Pediatric cardiologists have long speculated HFpEF in children with congenital heart disease and cardiomyopathy. However, understanding the risk factors, clinical course, and validated biomarkers predictive of the outcome of HFpEF in children is challenging due to heterogeneous etiologies and overlapping pathophysiological mechanisms. The natural history of HFpEF varies depending upon the patient’s age, sex, race, geographic location, nutritional status, biochemical risk factors, underlying heart disease, and genetic-environmental interaction, among other factors. Pediatric onset HFpEF is often not the same disease as in adults. Advances in the noninvasive evaluation of the LV diastolic function by strain, and strain rate analysis with speckle-tracking echocardiography, tissue Doppler imaging, and cardiac magnetic resonance imaging have increased our understanding of the HFpEF in children. This review addresses HFpEF in children and identifies knowledge gaps in the underlying etiologies, pathogenesis, diagnosis, and management, especially compared to adults with HFpEF.
引用
收藏
页码:513 / 529
页数:16
相关论文
共 50 条
  • [41] Heart Failure With Preserved Ejection Fraction In Perspective
    Pfeffer, Marc A.
    Shah, Amil M.
    Borlaug, Barry A.
    CIRCULATION RESEARCH, 2019, 124 (11) : 1598 - 1617
  • [42] Heart failure with preserved ejection fraction in Asia
    Tromp, Jasper
    Teng, Tiew-Hwa
    Tay, Wan Ting
    Hung, Chung Lieh
    Narasimhan, Calambur
    Shimizu, Wataru
    Park, Sang Weon
    Liew, Houng Bang
    Ngarmukos, Tachapong
    Reyes, Eugene B.
    Siswanto, Bambang B.
    Yu, Cheuk-Man
    Zhang, Shu
    Yap, Jonathan
    MacDonald, Michael
    Ling, Lieng Hsi
    Leineweber, Kirsten
    Richards, A. Mark
    Zile, Michael R.
    Anand, Inder S.
    Lam, Carolyn S. P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (01) : 23 - 36
  • [43] Heart Failure with Preserved Ejection Fraction in Women
    Tibrewala, Anjan
    Yancy, Clyde W.
    HEART FAILURE CLINICS, 2019, 15 (01) : 9 - 18
  • [44] Imaging in Heart Failure with Preserved Ejection Fraction
    Gupta, Deepak K.
    Solomon, Scott D.
    HEART FAILURE CLINICS, 2014, 10 (03) : 419 - +
  • [45] Treatment of Heart Failure with Preserved Ejection Fraction
    Iliesiu, Adriana Mihaela
    Hodorogea, Andreea Simona
    HEART FAILURE: FROM RESEARCH TO CLINICAL PRACTICE, VOL 3, 2018, 1067 : 67 - 87
  • [46] Finerenone in Heart Failure with Preserved Ejection Fraction
    Zhang, Jinshi
    Zhu, Bin
    Liu, Yueming
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (03): : 309 - 309
  • [47] Pathophysiology of Heart Failure with Preserved Ejection Fraction
    Youn, Jong-Chan
    Ahn, Yuran
    Jung, Hae Ok
    HEART FAILURE CLINICS, 2021, 17 (03) : 327 - 335
  • [48] Empagliflozin in Heart Failure with a Preserved Ejection Fraction
    不详
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (21):
  • [49] Managing heart failure with preserved ejection fraction
    Davidson, Alexander
    Raviendran, Nivashinie
    Murali, Charisma Nair
    Myint, Phyo Kyaw
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [50] Management of heart failure with preserved ejection fraction
    Gard, Emma
    Nanayakkara, Shane
    Kaye, David
    Gibbs, Harry
    AUSTRALIAN PRESCRIBER, 2020, 43 (01) : 12 - 17